HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Eliana Pivetta Selected Research

elastin microfibril interface located protein (emilin)

1/2022EMILIN-1 deficiency promotes chronic inflammatory disease through TGFβ signaling alteration and impairment of the gC1q/α4β1 integrin interaction.
10/2019Abrogation of EMILIN1-β1 integrin interaction promotes experimental colitis and colon carcinogenesis.
1/2019Integrin binding site within the gC1q domain orchestrates EMILIN-1-induced lymphangiogenesis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Eliana Pivetta Research Topics

Disease

11Neoplasms (Cancer)
08/2021 - 09/2012
3Carcinoma (Carcinomatosis)
05/2020 - 05/2013
2Stomach Neoplasms (Stomach Cancer)
05/2020 - 01/2019
2Ovarian Epithelial Carcinoma
12/2019 - 01/2017
2Carcinogenesis
10/2019 - 09/2012
2Prostatic Neoplasms (Prostate Cancer)
06/2017 - 05/2013
2Bone Resorption
10/2011 - 03/2011
1B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
04/2022
1Psoriasis (Pustulosis Palmaris et Plantaris)
01/2022
1Inflammation (Inflammations)
05/2020
1Ovarian Neoplasms (Ovarian Cancer)
02/2020
1Melanoma (Melanoma, Malignant)
01/2020
1Colitis
10/2019
1Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
10/2019
1Colonic Neoplasms (Colon Cancer)
10/2019
1Lymphedema (Milroy Disease)
01/2019
1Pain (Aches)
06/2017
1Rectal Neoplasms (Rectal Cancer)
01/2017
1Sarcoma (Soft Tissue Sarcoma)
02/2014
1Starvation
05/2013
1Neoplasm Metastasis (Metastasis)
10/2011
1Breast Neoplasms (Breast Cancer)
10/2011
1Coinfection
07/2003
1HIV Infections (HIV Infection)
07/2003

Drug/Important Bio-Agent (IBA)

3IntegrinsIBA
04/2022 - 04/2017
3elastin microfibril interface located protein (emilin)IBA
01/2022 - 01/2019
2LigandsIBA
04/2022 - 05/2013
2ElastinIBA
04/2022 - 05/2020
2Glycoproteins (Glycoprotein)IBA
01/2022 - 05/2020
2Pharmaceutical PreparationsIBA
08/2021 - 06/2017
2Interleukin-8 (Interleukin 8)IBA
05/2020 - 10/2011
2PlatinumIBA
12/2019 - 01/2017
2Conditioned Culture MediaIBA
05/2013 - 10/2011
1Fibronectins (Fibronectin)IBA
04/2022
1Integrin alpha4beta1 (VLA-4)IBA
04/2022
1Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA
04/2022
1Oxygen (Dioxygen)IBA
08/2021
1CytokinesIBA
05/2020
1B7-H1 AntigenIBA
02/2020
1ParaffinIBA
02/2020
1Mitogen-Activated Protein KinasesIBA
01/2020
1Tissue Inhibitor of Metalloproteinase-1IBA
12/2019
1ElementsIBA
10/2019
1Proteins (Proteins, Gene)FDA Link
01/2019
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
06/2017
1Zoledronic Acid (Zometa)FDA Link
06/2017
1Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA
06/2017
1Interleukin-6 (Interleukin 6)IBA
06/2017
1Extracellular Matrix ProteinsIBA
04/2017
1Biological ProductsIBA
01/2017
1Leukocyte Elastase (Neutrophil Elastase)IBA
02/2014
1Pancreatic Elastase (Elastase)IBA
02/2014
1ErbB Receptors (EGF Receptor)IBA
05/2013
1Tyrosine Kinase InhibitorsIBA
05/2013
1Gefitinib (Iressa)FDA Link
05/2013
1Docetaxel (Taxotere)FDA Link
05/2013
1anthraceneIBA
09/2012
1Acetates (Acetic Acid Esters)FDA Link
09/2012
1Matrix Metalloproteinase 14 (MT1-MMP)IBA
10/2011
1Matrix Metalloproteinase InhibitorsIBA
10/2011
1CollagenIBA
03/2011
1DNA (Deoxyribonucleic Acid)IBA
07/2003
1RNA (Ribonucleic Acid)IBA
07/2003

Therapy/Procedure

5Therapeutics
05/2020 - 01/2017
2Lasers (Laser)
01/2019 - 01/2017